Cargando…

Acetaminophen: A Liver Killer or Thriller

Acetaminophen, or paracetamol, ranks among the most extensively utilized analgesic and antipyretic medications globally. The administration of acetaminophen to individuals with underlying liver disease has long sparked concerns regarding the potential risk of hepatotoxicity. However, the available l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacharia, George S, Jacob, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645398/
https://www.ncbi.nlm.nih.gov/pubmed/38022064
http://dx.doi.org/10.7759/cureus.47071
_version_ 1785134744970723328
author Zacharia, George S
Jacob, Anu
author_facet Zacharia, George S
Jacob, Anu
author_sort Zacharia, George S
collection PubMed
description Acetaminophen, or paracetamol, ranks among the most extensively utilized analgesic and antipyretic medications globally. The administration of acetaminophen to individuals with underlying liver disease has long sparked concerns regarding the potential risk of hepatotoxicity. However, the available literature and recommendations consider it a safe option in all forms of liver diseases and is deemed safe when used at recommended doses. This article aims to offer a concise review of the pharmacokinetics, toxicity profile, and the intricate considerations surrounding the safety of acetaminophen in patients with liver disease. By delving into the liver-acetaminophen interactions, we seek to provide a nuanced perspective on the use of acetaminophen in this critical patient population.
format Online
Article
Text
id pubmed-10645398
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106453982023-10-15 Acetaminophen: A Liver Killer or Thriller Zacharia, George S Jacob, Anu Cureus Gastroenterology Acetaminophen, or paracetamol, ranks among the most extensively utilized analgesic and antipyretic medications globally. The administration of acetaminophen to individuals with underlying liver disease has long sparked concerns regarding the potential risk of hepatotoxicity. However, the available literature and recommendations consider it a safe option in all forms of liver diseases and is deemed safe when used at recommended doses. This article aims to offer a concise review of the pharmacokinetics, toxicity profile, and the intricate considerations surrounding the safety of acetaminophen in patients with liver disease. By delving into the liver-acetaminophen interactions, we seek to provide a nuanced perspective on the use of acetaminophen in this critical patient population. Cureus 2023-10-15 /pmc/articles/PMC10645398/ /pubmed/38022064 http://dx.doi.org/10.7759/cureus.47071 Text en Copyright © 2023, Zacharia et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Zacharia, George S
Jacob, Anu
Acetaminophen: A Liver Killer or Thriller
title Acetaminophen: A Liver Killer or Thriller
title_full Acetaminophen: A Liver Killer or Thriller
title_fullStr Acetaminophen: A Liver Killer or Thriller
title_full_unstemmed Acetaminophen: A Liver Killer or Thriller
title_short Acetaminophen: A Liver Killer or Thriller
title_sort acetaminophen: a liver killer or thriller
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645398/
https://www.ncbi.nlm.nih.gov/pubmed/38022064
http://dx.doi.org/10.7759/cureus.47071
work_keys_str_mv AT zachariageorges acetaminophenaliverkillerorthriller
AT jacobanu acetaminophenaliverkillerorthriller